Lexaria Bioscience logo

Lexaria Bioscience Share Price Today

(NASDAQ: LEXX)

Lexaria Bioscience share price is $1.38 & ₹120.02 as on 6 Mar 2025, 2.30 'hrs' IST

$1.38

0.17

(14.05%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Lexaria Bioscience share price in Dollar and Rupees. Guide to invest in Lexaria Bioscience stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Lexaria Bioscience, along with analyst recommendations, forecasts, and comprehensive financials.

Lexaria Bioscience share price movements

  • Today's Low: $1.20
    Today's High: $1.44

    Day's Volatility :16.82%

  • 52 Weeks Low: $1.15
    52 Weeks High: $6.85

    52 Weeks Volatility :83.21%

Lexaria Bioscience (LEXX) Returns

PeriodLexaria Bioscience CorpIndex (Russel 2000)
3 Months
-41.03%
0.0%
6 Months
-58.18%
0.0%
1 Year
-69.2%
0.0%
3 Years
-59.17%
-11.6%

Lexaria Bioscience (LEXX) Key Statistics

in dollars & INR

Previous Close
$1.21
Open
$1.2
Today's High
$1.4427
Today's Low
$1.2
Market Capitalization
$21.2M
Today's Volume
$97.4K
52 Week High
$6.85
52 Week Low
$1.15
Revenue TTM
$496.9K
EBITDA
$-7.2M
Earnings Per Share (EPS)
$-0.47
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-114.83%

How to invest in Lexaria Bioscience Stock (LEXX) from India?

It is very easy for Indian residents to invest directly in Lexaria Bioscience from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Lexaria Bioscience stock in both Indian Rupees (INR) and US Dollars (USD). Search for Lexaria Bioscience or LEXX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Lexaria Bioscience or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Lexaria Bioscience shares which would translate to 0.630 fractional shares of Lexaria Bioscience as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Lexaria Bioscience, in just a few clicks!

Returns in Lexaria Bioscience (LEXX) for Indian investors in Rupees

The Lexaria Bioscience stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Lexaria Bioscience investment value today

Current value as on today

₹35,752

Returns

₹64,248

(-64.25%)

Returns from Lexaria Bioscience Stock

₹69,196 (-69.2%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Lexaria Bioscience (LEXX)

-23%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Lexaria Bioscience Stock from India on INDmoney has decreased by -23% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Lexaria Bioscience

  • Armistice Capital, LLC

    2.62%

  • Invenomic Capital Management, LP

    2.34%

  • Geode Capital Management, LLC

    0.95%

  • Vanguard Group Inc

    0.73%

  • Raymond James Finl Svs Advisors, Inc.

    0.26%

  • State Street Corp

    0.22%

Analyst Recommendation on Lexaria Bioscience

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Lexaria Bioscience(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Lexaria Bioscience Stock (LEXX)

What analysts predicted

Upside of 552.17%

Target:

$9.00

Current:

$1.38

Insights on Lexaria Bioscience Stock (Ticker Symbol: LEXX)

  • Price Movement

    In the last 7 days, LEXX stock has moved down by -11.0%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 84.0K → 183.92K (in $), with an average increase of 54.3% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 4 quarters, -649.53K → -2.70M (in $), with an average decrease of 73.6% per quarter
  • LEXX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.5% return, outperforming this stock by 135.7%
  • LEXX vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 51.6% return, outperforming this stock by 110.0%
  • Price to Sales

    ForLEXX every $1 of sales, investors are willing to pay $39.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.2 for every $1 of sales.

Lexaria Bioscience Technicals Summary

Sell

Neutral

Buy

Lexaria Bioscience is currently in a neutral trading position according to technical analysis indicators.

Lexaria Bioscience (LEXX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Lexaria Bioscience Corp logo
-22.03%
-58.18%
-69.2%
-59.17%
-69.2%
Regeneron Pharmaceuticals, Inc. logo
-1.42%
-40.28%
-29.31%
11.08%
44.83%
Beone Medicines Ltd logo
17.63%
36.87%
64.37%
45.89%
71.3%
Vertex Pharmaceuticals Incorporated logo
1.94%
4.92%
19.37%
108.73%
123.83%
Alnylam Pharmaceuticals, Inc. logo
-8.03%
-0.89%
66.53%
52.9%
126.66%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Lexaria Bioscience Corp logo
NA
NA
NA
0.0
-1.15
-0.67
NA
0.56
Regeneron Pharmaceuticals, Inc. logo
17.86
17.86
1.01
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.34
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Lexaria Bioscience Corp logo
Buy
$21.2M
-69.2%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$73.8B
44.83%
17.86
31.07%
Beone Medicines Ltd logo
NA
$29.1B
71.3%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.9B
123.83%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.4B
126.66%
NA
-12.37%

About Lexaria Bioscience

Lexaria Bioscience Corp. operates as a biotechnology company. It offers its patented drug delivery-enabling platform technology, DehydraTECH, which combines active pharmaceutical ingredients (APIs) with specific long-chain fatty acid-rich triglyceride oils and carrier compounds that improve the way they enter the bloodstream, increasing their effectiveness and allowing for lower overall dosing for improved tolerability while promoting healthier oral ingestion methods. The company's DehydraTECH is used with a range of active molecules, including glucagon-like peptide-1 drugs (GLP-1) and glucose -dependent insulinotropic polypeptide drugs (GIP), vitamins, pain medications, hormones, phosphodiesterase type 5 (PDE5) inhibitors, antivirals, nicotine and its analogs, and cannabinoids. Its DehydraTECH technology is applied to various therapeutic indications, such as diabetes, weight loss, hypertension, and heart disease; is implemented in a multitude of ingestible or topically administered product formats comprising oral suspensions, tablets, capsules, foods, beverages, creams, lotions, and skin patches; and is suitable for a variety of product formats, including pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The company was formerly known as Lexaria Corp. and changed its name to Lexaria Bioscience Corp. in April 2016. Lexaria Bioscience Corp. was incorporated in 2004 and is headquartered in Kelowna, Canada.
Organization
Lexaria Bioscience
Employees
7
CEO
Mr. Richard C. Christopher
Industry
Miscellaneous

Management People of Lexaria Bioscience

NameTitle
Mr. Richard C. Christopher
CEO & Director
Mr. John M. Docherty M.Sc.
Chairman of the Scientific Advisory Board, Chief Scientific Officer, President & Director
Mr. Michael Shankman CPA
Chief Financial Officer
Ms. Kristin Hamilton
Director of Operations
Vanessa Carle
Head of Legal
Dr. C. Michael Gibson M.D., M.S.
Chief Medical Advisor & Member of Scientific Advisory Board

Important FAQs about investing in LEXX Stock from India :

What is Lexaria Bioscience share price today?

Lexaria Bioscience share price today stands at $1.38, Open: $1.20 ; Previous Close: $1.21 ; High: $1.44 ; Low: $1.20 ; 52 Week High: $6.85 ; 52 Week Low: $1.15.

The stock opens at $1.20, after a previous close of $1.21. The stock reached a daily high of $1.44 and a low of $1.20, with a 52-week high of $6.85 and a 52-week low of $1.15.

Can Indians buy Lexaria Bioscience shares?

Yes, Indians can invest in the Lexaria Bioscience (LEXX) from India.

With INDmoney, you can buy Lexaria Bioscience at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Lexaria Bioscience at zero transaction cost.

How can I buy Lexaria Bioscience shares from India?

It is very easy to buy Lexaria Bioscience from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Lexaria Bioscience (LEXX) be purchased?

Yes, you can buy fractional shares of Lexaria Bioscience with INDmoney app.

What are the documents required to start investing in Lexaria Bioscience stocks?

To start investing in Lexaria Bioscience, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Lexaria Bioscience Stock (LEXX)?

Today’s highest price of Lexaria Bioscience (LEXX) is $1.44.

Today’s lowest price of Lexaria Bioscience (LEXX) is $1.20.

What is today's market capitalisation of Lexaria Bioscience?

Today's market capitalisation of Lexaria Bioscience LEXX is 21.2M

What is the 52 Week High and Low Range of Lexaria Bioscience Stock (LEXX)?

  • 52 Week High

    $6.85

  • 52 Week Low

    $1.15

What are the historical returns of Lexaria Bioscience (LEXX)?

  • 1 Month Returns

    -22.03%

  • 3 Months Returns

    -58.18%

  • 1 Year Returns

    -69.2%

  • 5 Years Returns

    -69.2%

Who is the Chief Executive Officer (CEO) of Lexaria Bioscience ?

Mr. Richard C. Christopher is the current Chief Executive Officer (CEO) of Lexaria Bioscience.